Modulation of tau neuronal expression induced by NMDA, non-NMDA and metabotropic glutamate receptor agonists

P. Couratier, P. Sindou, F. Tabaraud, A. G. Diop, P. S. Spencer, Jaques Hugon

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


We have analysed changes in tau protein immunoreactivity in rat embryonic neurons degenerating in response to treatment with N-methyl-D-aspartate (NMDA), non-NMDA and metabotropic agonists. Glutamate agonists were applied in a Mg++-free and glycine-supplemented medium 8 days after initial plating. Cell viability was assessed by fluorescein diacetate staining and neuronal survival was evaluated by cell counting. Immunocytochemical and confocal laser microscopic studies used a tau2 monoclonal antibody. Acute and chronic NMDA treatment induced a concentration-dependent increase in intraneuronal tau immunoreactivity. Increased tau immunolabelling during chronic NMDA toxicity was dramatically attenuated by tetrodotoxin and also by 6-cyano-7-nitroquinoxaline-2,3-dione. Non-NMDA and metabotropic receptor agonist treatment produced a weaker augmentation in tau2 immunoreactivity. These findings suggest that, in this model, glutamate-receptor and sodium-channel coactivation are together needed to produce changes in tau immunoreactivity.

Original languageEnglish (US)
Pages (from-to)33-41
Number of pages9
Issue number1
StatePublished - Mar 1995


  • Glutamate
  • Metabotropic receptors
  • NMDA
  • Non-NMDA
  • Tau protein

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neuropsychology and Physiological Psychology
  • Clinical Neurology


Dive into the research topics of 'Modulation of tau neuronal expression induced by NMDA, non-NMDA and metabotropic glutamate receptor agonists'. Together they form a unique fingerprint.

Cite this